Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

CULLINAN ONCOLOGY, INC.

(CGEM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Sector news Other Biotechnology & Medical Research
06:28aIntron Health Lowers Price Target on Lonza Group, Maintains Hold Recommendation
MT
12:14aInsider Sell: Seagen
MT
01/26FDA advisers back the same COVID vaccine for initial shots, boosters
RE
01/26Moderna's Reported Plan to Increase COVID-19 Vaccine Price Raised Concerns From US Sena..
MT
01/26Transcript : IQVIA Holdings Inc. - Special Call
CI
01/25Cowen Adjusts Price Target on Moderna to $150 From $130, Maintains Market Perform Ratin..
MT
01/25Berenberg Adjusts Price Target on Seagen to $170 From $183, Maintains Buy Rating
MT
01/25Transcript : IQVIA Holdings Inc. - Special Call
CI
01/25Lonza Group AG Provides Earnings Guidance for the Year 2023
CI
01/25Lonza Group Seeks Mergers and Acquisitions
CI
01/25Transcript : Lonza Group AG, 2022 Earnings Call, Jan 25, 2023
CI
01/25Lonza Sweetens Shareholder Returns After COVID-19-related Sales Peak Drives 2022 Result..
MT
01/25Lonza Shares Fall But Regain Ground Following 2022 Result
DJ
01/25European shares slip as investors weigh earnings reports
RE
01/25Lonza's 2022 Core Earnings and Sales Increased; Plans a Share Buyback
DJ
01/25Lonza Group Profit Balloons 80% in 2022 Amid 15% Increase in Sales
MT
01/25Lonza underscores growth prospects with share buy-back, dividend hike
RE
01/25Swiss Manufacturer Lonza Plans CHF2 Billion Buyback On SIX Swiss Exchange
MT
01/25Switzerland's Lonza Affirms Mid-term FY24 Outlook As 2022 Sales Climb 15%
MT
01/25Lonza Group AG Reports Earnings Results for the Full Year Ended December 31, 2022
CI
01/25Lonza Group AG announces an Equity Buyback for CHF 2,000 million worth of its shares.
CI
01/25Lonza Group AG authorizes a Buyback Plan.
CI
01/24Transcript : IQVIA Holdings Inc. - Special Call
CI
01/24Transcript : IQVIA Holdings Inc. - Special Call
CI
01/24Transcript : IQVIA Holdings Inc. - Special Call
CI
01/24Morgan Stanley Adjusts Moderna Price Target to $205 From $209, Maintains Equal Weight R..
MT
01/24Transcript : IQVIA Holdings Inc. - Special Call
CI
01/23SVB Securities Adjusts Price Target on Alnylam Pharmaceuticals to $143 From $144, Maint..
MT
01/23U.S. FDA proposes shift to annual COVID vaccine shots
RE
01/23U.S. FDA proposes to simplify COVID vaccine strategy
RE
01/23Insider Sell: Moderna
MT
01/20Insider Sell: Moderna
MT
01/20SVB Securities Adjusts Price Target on Seagen to $162 From $160, Maintains Outperform R..
MT
01/19Seagen Gets FDA Accelerated Approval for Colorectal Cancer Drug Tukysa
MT
01/19Seagen Gets FDA Accelerated Approval for Tukysa
DJ
01/19US FDA Grants Approval to Seagen's Tukysa to Treat Colorectal Cancer
MT
01/19Seagen Inc. Announces FDA Approval of Tukysa in Combination with Trastuzumab for People..
CI
01/19Davos 2023: What you need to know about the WEF on Thursday
RE
01/18Retail Sales, Producer Price Data Drag Equities Lower
MT
01/18Wall St sinks after weak data, hawkish Fed comments
RE
01/18Retail Sales, Producer Price Data Drag Equities Lower
MT
01/18Wall St closes lower after weak data, hawkish Fed comments
RE
01/18Wall St stumbles after weak data, hawkish Fed comments
RE
01/18Retail Sales, Producer Price Data Drive US Equities Lower
MT
01/18Slumping Treasury Yields Following Lower Retail Sales, Producer Prices Keep US Equity I..
MT
01/18Dow Sinks 350 Points After Retail Sales, Producer Prices Slump More Than Forecast
MT
01/18Transcript : IQVIA Holdings Inc. - Special Call
CI
01/18Wall Street reverses gains as hawkish Fed officials douse easing inflation cheer
RE
01/18SVB Securities Adjusts Price Target on Moderna to $111 From 102, Maintains Market Perfo..
MT
01/18Global markets live: BASF, United Airlines, Microsoft, Pfizer, Apple..
MS
01/18Chardan Adjusts Moderna's Price Target to $208 From $191, Keeps Neutral Rating
MT
01/18Canaccord Genuity Starts Alnylam Pharmaceuticals at Buy With $310 Price Target
MT
01/18Sector Update: Health Care Stocks Higher Pre-Bell Wednesday
MT
01/18Sector Update: Health Care
MT
01/18Moderna CEO Discussed Supply of COVID Vaccines With China
MT
01/18Moderna RSV Vaccine Candidate Meets Primary Efficacy Endpoints in Late-Stage Trial -- S..
MT
01/18Trending : Moderna Sees Positive Data in Experimental RSV Vaccine
DJ
01/18Davos 2023: Moderna CEO in talks with China to supply COVID vaccines
RE
01/17Moderna Says RSV Vaccine Candidate Meets Primary Efficacy Endpoints in Late-Stage Trial..
MT
01/17Moderna Shares Up 4.8% After-Hours on Trial Results for RSV Vaccine
DJ
01/17Moderna Announces mRNA-1345, an Investigational Respiratory Syncytial Virus Vaccine, Ha..
CI
01/17Moderna says RSV vaccine 84% effective at preventing symptoms in older adults
RE
01/17Barclays Adjusts Price Target on IQVIA Holdings to $260 From $235, Maintains Overweight..
MT
01/17Insider Sell: Moderna
MT
01/16Lonza Completes Expansion At US Facility
MT
01/15US Health Regulators To Probe Pfizer-BioNTech COVID-19 Shot's Potential Link To Stroke
MT
01/13U.S. says Pfizer's bivalent COVID shot may be linked to stroke in older adults
RE
01/13Insider Sell: Moderna
MT
01/13Baird Adjusts Price Target on IQVIA Holdings to $260 From $266, Maintains Outperform Ra..
MT
01/12AlphaValue/Baader Europe Lifts Price Target on Lonza Group, Maintains Add Recommendatio..
MT
01/11Transcript : Lonza Group AG Presents at 41st Annual J.P. Morgan Healthcare Co..
CI
01/11Deutsche Bank Adjusts Moderna's Price Target to $225 From $185, Maintains Buy Rating
MT
01/10Sen. Sanders asks Moderna not to hike COVID vaccine price
RE
01/10Senator Bernie Sanders Asks Moderna Not to Raise COVID-19 Vaccine's Price
MT
01/10US Senator Sanders Asks Moderna to Halt Planned COVID-19 Vaccine Price Increase
MT
01/10Pieris Pharmaceuticals Says it Achieves $5 Million Seagen Milestone
MT
01/10Sen. Sanders asks Moderna not to hike COVID vaccine price
RE
01/09Moderna Mulls Increased Pricing For Commercial Distribution Of COVID-19 Jab
MT
01/09Transcript : Seagen Inc. Presents at 41st Annual J.P. Morgan Healthcare Confe..
CI
01/09Transcript : Moderna, Inc. Presents at 41st Annual J.P. Morgan Healthcare Con..
CI
01/09Moderna Reportedly Mulling $110 to $130 Price Range for COVID-19 Shot
MT
01/09Moderna Looks for Potential Approval of 2 new Vaccines in 2023, CEO Stephane Bancel Say..
MT
01/09Moderna Meets Guidance for 2022 COVID-19 Vaccine Sales, Reiterates 2023 Target
MT
01/09Moderna considers pricing COVID vaccine at $110-$130 - WSJ
RE
01/09Moderna to Consider Price of $110 to $130 for Covid..
MT
01/09Moderna considers pricing COVID vaccine at $110-$130 - WSJ
RE
01/09Moderna Considers Price Of $110-$130 For Covid-19 Vaccine - WSJ
RE
01/09Transcript : Alnylam Pharmaceuticals, Inc. Presents at 41st Annual J.P. Morga..
CI
01/09Global markets live: Alibaba, Qiagen, Macy's, Oracle, Chevron...
MS
01/09Moderna Raises 2023 R&D Investments to $4.5 Billion
MT
01/09Context Therapeutics and Lonza Enter Manufacturing Agreement for Bispecific Antibody Ta..
CI
01/09Moderna meets forecast with $18.4 billion in COVID vaccine sales in 2022
RE
01/09Moderna generates $18.4 billion in COVID vaccine sales in 2022
RE
01/09Tranche Update on Moderna, Inc.'s Equity Buyback Plan announced on August 3, 2022.
CI
01/09Ocugen-Bharat Biotech COVID vaccine meets main goals in U.S. trial
RE
01/09Deutsche Bank Lowers Price Target on Lonza Group, Maintains Buy Recommendation
MT
01/09Insider Sell: Seagen
MT
01/09Insider Sell: Moderna
MT
01/06Chinese-made mRNA vaccine starts trial production
RE
01/06Insider Sell: Moderna
MT